ID: ALA492662

Max Phase: Preclinical

Molecular Formula: C13H24N6

Molecular Weight: 264.38

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCN(CC)c1cc(N2CCN(C)CC2)nc(N)n1

Standard InChI:  InChI=1S/C13H24N6/c1-4-18(5-2)11-10-12(16-13(14)15-11)19-8-6-17(3)7-9-19/h10H,4-9H2,1-3H3,(H2,14,15,16)

Standard InChI Key:  BWEFMDLNLUWTEB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 264.38

Molecular Weight (Monoisotopic): 264.2062

AlogP: 0.66

#Rotatable Bonds: 4

Polar Surface Area: 61.52

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa: 7.46

CX LogP: 1.87

CX LogD: 1.33

Aromatic Rings: 1

Heavy Atoms: 19

QED Weighted: 0.86

Np Likeness Score: -1.80

References

1. Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD..  (2008)  Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.,  51  (20): [PMID:18811133] [10.1021/jm8005959]

Source

Source(1):

• Scientific Literature